EULAR 2025 highlights… EULAR 2025 Highlights – SLE and APS 18 Jul 2025 Preliminary results of CD19/BCMA Dual-Targeting FasTCAR-T Cells GC012F (AZD0120) in patients with refractory Systemic Lupus Erythematosus-an open-label, single-arm study Abstract format and assignment number: Oral presentation OP0074 Date: Wednesday, 11…
EULAR 2025 highlights… EULAR 2025 Highlights – Other Connective Tissue Diseases and Vasculitis 18 Jul 202522 Jul 2025 EFFICACY AND SAFETY OF EFGARTIGIMOD PH20 SC IN ADULT PARTICIPANTS WITH ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHY: PHASE 2 RESULTS FROM THE ALKIVIA STUDY Abstract format and assignment number: Oral presentation OP0002 Date: Wednesday,…
EULAR 2025 highlights… EULAR 2025 Highlights- Rheumatoid Arthritis: Clinical (therapeutic) 18 Jul 2025 Cancer Risk in Patients with Rheumatoid Arthritis Receiving Biologic and Targeted Synthetic Disease Modifying Antirheumatic Drugs: Data from a Multicenter National Real-World Registry Abstract format and assignment number: Oral presentation…
EULAR 2025 highlights… EULAR 2025 Highlights- Rheumatoid Arthritis: Clinical (non-therapeutic) 18 Jul 202518 Jul 2025 Trends in Incidence and Predictors of Incident Venous Thromboembolism in Patients with Rheumatoid Arthritis: A Population-Based Retrospective Cohort Study Abstract format and assignment number: Oral presentation OP0070 Presenting author: E…
EULAR 2025 highlights… EULAR 2025 Highlights – Spondyloarthritis: Clinical (therapeutic) 18 Jul 2025 Superior effectiveness and comparable drug retention of anti-TNF therapy versus anti-IL-17A in ankylosing spondylitis after first anti-TNF failure: A propensity score-matched analysis from the Czech ATTRA Registry Abstract format and…
EULAR 2025 highlights… EULAR 2025 Highlights – Spondyloarthritis: Clinical (non-therapeutic) 18 Jul 2025 Impact of Residual Disease on Disease Flares in Axial Spondyloarthritis: A Longitudinal Study in a Dutch Clinical Practice Registry Abstract format and assignment number: Oral presentation OP0097 Date: Wednesday, 11…
EULAR 2025 highlights… EULAR 2025 Highlights – Osteoarthritis & Osteoporosis 18 Jul 2025 Phase I/II trial of Allocetra™ cell therapy for knee osteoarthritis: clinical evidence of response to modulation of inflammation Abstract format and assignment number: Poster POS0684 Presenting author: E. Galamidi (Israel) Date:…
Basic and Translational Research… EULAR 2025 Highlights – Basic And Translational Research (Genetics, cartilage, osteoimmunology and animal models) 18 Jul 202518 Jul 2025 Treatment of Refractory Systemic Lupus Erythematosus with Off-the-Shelf iPSC-derived Anti-CD19 CAR T-cell Therapy Abstract format and assignment number: Oral presentation OP0032 Date: Wednesday 11th June 2025, 15:20 Presenting author: V…
Basic Research II- Immunity, Immunology… EULAR 2025 Highlights – Basic And Translational Research (Immunity and Immunology) 18 Jul 202518 Jul 2025 Multitargeted biological actions of polydatin in preventing pseudogout acute attack Abstract format and assignment number: Oral presentation OP0131 Presenting author: F Oliviero (Italy) Date: Thursday 12th June 2025, 10:30 Polydatin…
EULAR 2025 highlights… EULAR 2025 Highlights – Rare and Autoinflammatory diseases 18 Jul 202518 Jul 2025 A WINDOW OF OPPORTUNITY IN STILL’S DISEASE: THE EARLY INTRODUCTION OF IL-1 INHIBITORS FOR ACHIEVING CLINICAL INACTIVE DISEASE Abstract format and assignment number: Poster 0377 Presenting author: S. Bindoli (Italy)…